HTV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell―mediated killingRICHARD, Jonathan; SINDHU, Sardar; PHAM, Tram N. Q et al.Blood. 2010, Vol 115, Num 7, pp 1354-1363, issn 0006-4971, 10 p.Article

Simultaneous engagement of the activatory receptors NKG2D and CD3 for retargeting of effector cells to CD33-positive malignant cellsSTAMOVA, S; CARTELLIERI, M; RIEBER, E. P et al.Leukemia. 2011, Vol 25, Num 6, pp 1053-1056, issn 0887-6924, 4 p.Article

RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in LymphomaLAM, Adeline R; LE BERT, Nina; RAULET, David H et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 8, pp 2193-2203, issn 0008-5472, 11 p.Article

Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA^*008 That Is Shed by Tumor Cells in ExosomesASHIRU, Omodele; BOUTET, Philippe; FERNANDEZ-MESSINA, Lola et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 2, pp 481-489, issn 0008-5472, 9 p.Article

Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptorTONG ZHANG; BARBER, Amorette; SENTMAN, Charles L et al.Cancer research (Baltimore). 2006, Vol 66, Num 11, pp 5927-5933, issn 0008-5472, 7 p.Article

A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor CellsCHANG, Yu-Hsiang; CONNOLLY, John; SHIMASAKI, Noriko et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 6, pp 1777-1786, issn 0008-5472, 10 p.Article

Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicityKELLNER, C; HALLACK, D; REPP, R et al.Leukemia. 2012, Vol 26, Num 4, pp 830-834, issn 0887-6924, 5 p.Article

High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomasRAFFAELLA ZOCCHI, Maria; CATELLANI, Silvia; RAVETTI, Jean-Louis et al.Blood. 2012, Vol 119, Num 6, pp 1479-1489, issn 0006-4971, 11 p.Article

Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infectionMUNTASELL, Aura; MAGRI, Giuliana; PENDE, Daniela et al.Blood. 2010, Vol 115, Num 25, pp 5170-5179, issn 0006-4971, 10 p.Article

TNK cells (NKG2D⁺ CD8⁺ or CD4⁺ T lymphocytes) in the control of human tumorsMACCALLI, Cristina; SCARAMUZZA, Samantha; PARMIANI, Giorgio et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 5, pp 801-808, issn 0340-7004, 8 p.Article

Induction of NKG2D Ligands and Subsequent Enhancement of NK Cell-mediated Lysis of Cancer Cells by Arsenic TrioxideKIM, Joo-Young; BAE, Jae-Ho; LEE, Sang-Hwa et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 5, pp 475-486, issn 1524-9557, 12 p.Article

The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cellsEL-SHERBINY, Yasser M; MEADE, Josephine L; MORGAN, Gareth J et al.Cancer research (Baltimore). 2007, Vol 67, Num 18, pp 8444-8449, issn 0008-5472, 6 p.Article

TNFα stimulates NKG2D-mediated lytic activity of acute myeloid leukemic cellsGUILLOTON, F; DE THONEL, A; JEAN, C et al.Leukemia. 2005, Vol 19, Num 12, pp 2206-2214, issn 0887-6924, 9 p.Article

Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor inductionKONJEVIC, G; MIRJACIC MARTINOVIC, K; VULETIC, A et al.Biomedicine & pharmacotherapy. 2010, Vol 64, Num 10, pp 663-671, issn 0753-3322, 9 p.Article

Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillanceHAYASHI, Tomonori; IMAI, Kazue; MORISHITA, Yukari et al.Cancer research (Baltimore). 2006, Vol 66, Num 1, pp 563-570, issn 0008-5472, 8 p.Article

NKp46 and NKG2D receptor expression in NK cells with CD56^dim and CD56^bright phenotype : regulation by histamine and reactive oxygen speciesROMERO, Ana I; THOREN, Fredrik B; BRUNE, Mats et al.British journal of haematology. 2006, Vol 132, Num 1, pp 91-98, issn 0007-1048, 8 p.Article

Soluble MICA in malignant diseasesHOLDENRIEDER, Stefan; STIEBER, Petra; PETERFI, Andrea et al.International journal of cancer. 2006, Vol 118, Num 3, pp 684-687, issn 0020-7136, 4 p.Article

NKG2D and its ligands: active factors in the outcome of solid organ transplantation?SUAREZ-ALVAREZ, Beatriz; FERNANDEZ-SANEHEZ, Alba; LOPEZ-VAZQUEZ, Antonio et al.Kidney international supplements (Print). 2011, Vol 1, Num 2, pp 52-57, issn 2157-1724, 6 p.Conference Paper

Effect of NKG2D ligand expression on host immune responsesCHAMPSAUR, Marine; LANIER, Lewis L.Immunological reviews. 2010, Vol 235, pp 267-285, issn 0105-2896, 19 p.Article

Soluble MICB in malignant diseases : analysis of diagnostic significance and correlation with soluble MICAHOLDENRIEDER, Stefan; STIEBER, Petra; PETERFI, Andrea et al.Cancer immunology and immunotherapy. 2006, Vol 55, Num 12, pp 1584-1589, issn 0340-7004, 6 p.Article

The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46-and NKG2D-activating receptors and regulates NK-cell functionCHIESA, Mariella Della; CARLOMAGNO, Simona; FRUMENTO, Guido et al.Blood. 2006, Vol 108, Num 13, pp 4118-4125, issn 0006-4971, 8 p.Article

Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cellsCOUDERT, Jérome D; ZIMMER, Jacques; TOMASELLO, Elena et al.Blood. 2005, Vol 106, Num 5, pp 1711-1717, issn 0006-4971, 7 p.Article

The Combination of Anti-NKG2D and CTLA-4 Ig Therapy Prolongs Islet Allograft Survival in a Murine ModelPAWLICK, R; GALA-LOPEZ, B; PEPPER, A. R et al.American journal of transplantation (Print). 2014, Vol 14, Num 10, pp 2367-2374, issn 1600-6135, 8 p.Article

Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2DHEINEMANN, Anja; FANG ZHAO; PECHLIVANIS, Sonali et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 2, pp 460-471, issn 0008-5472, 12 p.Article

Human NK Cells Are Alerted to Induction of p53 in Cancer Cells by Upregulation of the NKG2D Ligands ULBP1 and ULBP2TEXTOR, Sonja; FIEGLER, Nathalie; ARNOLD, Annette et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 18, pp 5998-6009, issn 0008-5472, 12 p.Article